Teladoc Health, Inc. (TDOC)
NYSE: TDOC · IEX Real-Time Price · USD
9.09
-0.22 (-2.36%)
At close: Jul 19, 2024, 4:00 PM
9.16
+0.07 (0.77%)
Pre-market: Jul 22, 2024, 7:47 AM EDT
Teladoc Health Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for Teladoc Health stock have an average target of 19.03, with a low estimate of 10 and a high estimate of 28. The average target predicts an increase of 109.35% from the current stock price of 9.09.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Teladoc Health stock from 19 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 9 | 8 | 11 | 12 | 12 | 13 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 14 | 17 | 18 | 18 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $14 → $10 | Hold | Maintains | $14 → $10 | +10.01% | Jul 9, 2024 |
| JP Morgan | JP Morgan | Hold Maintains $19 → $16 | Hold | Maintains | $19 → $16 | +76.02% | May 21, 2024 |
| B of A Securities | B of A Securities | Hold Maintains $17 → $14 | Hold | Maintains | $17 → $14 | +48.51% | May 14, 2024 |
| Wells Fargo | Wells Fargo | Hold Maintains $17 → $15 | Hold | Maintains | $17 → $15 | +65.02% | Apr 29, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $26 → $21 | Buy | Maintains | $26 → $21 | +131.02% | Apr 26, 2024 |
Financial Forecast
Revenue This Year
2.71B
from 2.60B
Increased by 4.21%
Revenue Next Year
2.81B
from 2.71B
Increased by 3.61%
EPS This Year
-1.09
from -1.34
EPS Next Year
-0.62
from -1.09
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.8B | 3.0B | 3.1B | 3.3B | 3.5B |
| Avg | 2.7B | 2.8B | 2.9B | 3.1B | 3.2B |
| Low | 2.6B | 2.6B | 2.7B | 2.9B | 3.0B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 8.3% | 9.4% | 10.6% | 11.5% | 13.2% |
| Avg | 4.2% | 3.6% | 4.0% | 4.4% | 6.1% |
| Low | -1.2% | -2.6% | -2.4% | -2.4% | -1.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.84 | 0.76 | 0.36 | -0.41 | 0.07 |
| Avg | -1.09 | -0.62 | -0.53 | -0.40 | 0.07 |
| Low | -1.19 | -1.16 | -0.82 | -0.38 | 0.07 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.